All News about Veracyte Inc
Earnings Outlook For Veracyte
February 21, 2024
Via Benzinga
Veracyte Completes Acquisition of C2i Genomics
February 06, 2024
From Veracyte, Inc.
Via Business Wire
Veracyte: Q3 Earnings Insights
November 07, 2023
Via Benzinga
From Veracyte, Inc.
Via Business Wire
The Latest Analyst Ratings for Veracyte
October 20, 2023
Via Benzinga
Veracyte Announces Third Quarter 2023 Financial Results
November 07, 2023
From Veracyte, Inc.
Via Business Wire
Veracyte to Participate in the Stephens Annual Investment Conference
November 02, 2023
From Veracyte, Inc.
Via Business Wire
From Veracyte, Inc.
Via Business Wire
Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer
September 27, 2023
From Veracyte, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|